Showing results (201-210 of 283) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|March 10, 2023
HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric miceTakuro Uchida, Michio Imamura, C Nelson Hayes, et al.
Journal of Gastroenterology and Hepatology|August 12, 2016
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patientsKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 26, 2017
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinomaYuji Teraoka, Tomoki Kimura, Hiroshi Aikata, et al.
The Journal of Infection|December 26, 2021
Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibodyHaruna Hatooka, Yumi Shimomura, Michio Imamura, et al.
Antiviral Therapy|September 22, 2017
The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patientsMio Kurihara, Masataka Tsuge, Eisuke Murakami, et al.
Journal of Gastroenterology|August 18, 2017
Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot studyYoshiiku Kawakami, Hidenori Ochi, Clair Nelson Hayes, et al.
Journal of Gastroenterology|February 22, 2019
Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric miceKen Tsushima, Masataka Tsuge, Nobuhiko Hiraga, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2022
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular CarcinomaYumi Kosaka, Tomokazu Kawaoka, Masanari Kosaka, et al.
Anticancer Research|June 30, 2016
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial ChemoembolizationMasahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, et al.
Journal of Gastroenterology and Hepatology|July 21, 2023
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failureSerami Murakami, Takuro Uchida, Michio Imamura, et al.
Pageof 29